EDGAR Filing Documents for 0001178913-23-003602

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001178913-23-003602

Filing Date

2023-11-09

Accepted

2023-11-09 08:00:12

Documents

Period of Report

2023-11-09

Document Format Files

Seq	Description	Document	Type	Size
1	6-K	zk2330497.htm	6-K	11432
2	EXHIBIT 99.1	exhibit_99-1.htm	EX-99.1	476683
3	EXHIBIT 99.2	exhibit_99-2.htm	EX-99.2	156129
4		image00001.jpg	GRAPHIC	21607
	Complete submission text file	0001178913-23-003602.txt		675281

Mailing Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002

Business Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002 972-77-331-0156

Chemomab Therapeutics Ltd. (Filer) CIK: 0001534248 (see all company filings)

IRS No.: 813676773 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38807 | Film No.: 231390126
SIC: 2834 Pharmaceutical Preparations